PCM Trials, EmVenio Research, and Clinical Trial Service Consolidate Under EmVenio Clinical Research Brand
核心洞察
PCM Trials (搜索) and its subsidiaries EmVenio Research (搜索) and Clinical Trial Service (搜索) have unified under the single brand name EmVenio Clinical Research (搜索) to enhance global clinical trial accessibility.
The consolidated organization now operates in over 80 countries with approximately 5,000 professionals, maintaining a proven track record of recruiting over 75% minority patients and retaining more than 92% of trial participants.
EmVenio has launched Patient Navigator, a new personalized support service designed to reduce logistical and financial barriers to clinical trial participation, particularly for rare diseases (搜索) and pediatric studies.
Three leading clinical research organizations have consolidated under a unified brand to expand global access to clinical trials. PCM Trials (搜索), along with its subsidiaries EmVenio Research (搜索) and Clinical Trial Service (搜索), announced their alignment under the single name EmVenio Clinical Research (搜索), creating a comprehensive platform designed to improve patient accessibility and participation in clinical studies.
Strategic Brand Consolidation
The consolidation brings together complementary capabilities from each organization under one entity, offering sponsors and contract research organizations enhanced flexibility and global reach. As a division of Professional Case Management (搜索), EmVenio Clinical Research (搜索) leverages a foundation of clinical expertise and compassionate care built over decades of experience.
"As we combine three uniquely strong and innovative companies, we are setting a new industry standard for reach, access and precision in community-based clinical research," said Greg Austin, president of PCM Trials (搜索) and now serving as president of EmVenio Clinical Research (搜索). "Joining forces solely under the EmVenio name will enable us to further succeed in making clinical research more approachable and accessible for participants to enroll and remain in studies."
Global Operations and Proven Performance
The unified organization now operates in over 80 countries with approximately 5,000 professionals supporting clinical trials worldwide. EmVenio Clinical Research (搜索) leverages mobile teams and local research sites to meet participants where they live and work, utilizing community-based sites and mobile research services to expand trial access.
The organization has demonstrated strong performance metrics, maintaining a proven track record of recruiting over 75% minority patients and retaining more than 92% of participants in trials. This success rate reflects the company's approach to bringing trials directly to patients in their homes, communities, and places they gather.
New Patient Navigator Service
Alongside the brand consolidation, EmVenio Clinical Research (搜索) has launched Patient Navigator, a personalized support service designed to reduce logistical and financial barriers to clinical trial participation. This service is particularly critical in therapeutic areas where trial participation can be burdensome for patients, such as rare diseases (搜索) and pediatrics.
Patient Navigator offers flexible participation support, including coordinated travel, lodging and reimbursement assistance. The service complements EmVenio's existing solutions such as remote, virtual and community-based visit opportunities, creating a comprehensive approach to meeting patients where they are and making trial participation more accessible.
Company Evolution and Acquisitions
PCM Trials (搜索) was founded in 2008 and became a global leader in decentralized clinical trials through specialty mobile nurse visits to clinical trial participants' homes. Many of the company's innovations have been adopted as standard practices in clinical research today.
In 2024, PCM Trials (搜索) acquired Clinical Trials Service, followed by the acquisition of EmVenio Research (搜索), forming the alliance that has now consolidated under the EmVenio Clinical Research (搜索) brand. The brand name combines the word "empower" and the Latin word "venio," meaning "to reach," reflecting the organization's mission to reach patients in ways traditional models cannot.
Industry Impact
The consolidation addresses a critical need in clinical research by focusing on populations that traditional trial models often miss. By bringing trials directly to patients and removing barriers to participation, EmVenio Clinical Research (搜索) aims to create a more complete and inclusive picture of human health.
The organization's approach emphasizes empathy, expertise and close collaboration, bridging the gap between science and the people it serves. This strategy aligns with industry trends toward more patient-centric clinical trial designs and improved accessibility for diverse patient populations.